menu
    • menu

    Company profile for Regenxbio

    NEW Drugs in Dev: 8
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. Through a single administration, our product candidates are designed to provide long-lasting e...
    REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. Through a single administration, our product candidates are designed to provide long-lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RegenxbioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9600 Blackwell Road, Suite 210, Rockville, MD 20850
    Telephone
    Telephone
    240.552.8181
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regenxbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Regenxbio, Novartis & Dyne Near FDA Filing for Muscular Dystrophy
    Regenxbio, Novartis & Dyne Near FDA Filing for Muscular Dystrophy

    26 May 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/regenxbio-novartis-dyne-near-fda-submissions-in-muscular-dystrophies

    BIOSPACE
    26 May 2026
    Share Share
    REGENXBIO To Participate In Upcoming Investor Conferences
    REGENXBIO To Participate In Upcoming Investor Conferences

    19 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302775147.html

    PR NEWSWIRE
    19 May 2026
    Share Share
    Regenxbio Hits Duchenne Milestone, Eyes 2027 FDA Approval
    Regenxbio Hits Duchenne Milestone, Eyes 2027 FDA Approval

    14 May 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/regenxbio-slumps-after-serious-side-effects-mar-Duchenne-gene therapy-results

    BIOSPACE
    14 May 2026
    Share Share
    REGENXBIO Reports Q1 2026 Financial Results
    REGENXBIO Reports Q1 2026 Financial Results

    14 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-reports-first-quarter-2026-financial-results-and-operational-highlights-302771841.html

    PR NEWSWIRE
    14 May 2026
    Share Share
    REGENXBIO to Present at ASGCT 2026 Annual Meeting
    REGENXBIO to Present at ASGCT 2026 Annual Meeting

    07 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-announces-presentations-at-the-american-society-of-gene--cell-therapy-2026-annual-meeting-302765129.html

    PR NEWSWIRE
    07 May 2026
    Share Share
    Gene Therapy's Evidence Problem—Lessons From Recent FDA Decisions
    Gene Therapy's Evidence Problem—Lessons From Recent FDA Decisions

    04 May 2026

    // BIOSPACE

    https://www.biospace.com/fda/opinion-gene-therapys-evidence-problem-lessons-from-recent-fda-decisions

    BIOSPACE
    04 May 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search